FundedIQ
Government and Military

Fab'entech

Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease. After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.

www.fabentech.com Lyon, France 11-50 employees
Total raised
$21.9M
Rounds
1
Latest
Series Unknown
Oct 2024

Fabentech is a privately owned biopharmaceutical SME based in Lyon (France) and created in 2009, which develops immunotherapies to address situations of emergency. In an environment where the globalization of trade accelerates the spread of epidemics and where the geopolitical context increases the risk of bioterrorist attacks, nations should be prepared to address various situations of public health & medical emergency. However, there is generally no real therapeutic option to fight acute symptoms arising from these neglected indications. Based on its horse F(ab’)2 platform, a fully-derisked technology in-licensed from Sanofi Pasteur, Fab’entech aims to provide therapeutic solutions in the fields of biodefense, drug intoxication and infectious disease. After having developed Fabenflu®, a product indicated for the treatment of avian influenza (H5N1) in human, Fab’entech is currently focusing on 3 products: a biodefense antidote developed in collaboration with the French army, a treatment for drug intoxication developed in a confidential indication, and an Ebola therapy developed with the support of the European Commission after having been identified by the WHO as the unique therapeutic solution in Europe in 2014.

Fab'entech has raised $21.9M across 1 round. Its most recent round was a Series Unknown of $21.9M in Oct 2024. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Oct 7, 2024
Series Unknown
$21.9M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

Fab'entech is featured in

Similar companies

BatiFire

BatiFire offers a risk prevention service that facilitates the connection between buildings and security and rescue teams.

Series Unknown $2.3M
Shark Robotics

The French industry pioneer for unmanned ground vehicles (UGVs) is Shark Robotics. Due to its expertise, Shark Robotics creates dependable, high-quality unmanned ground vehicles that combine strength, dependability, and durability. Shark Robotics offers a variety of robots that are ready to be deployed as well as custom robots that are created to meet the needs of the customer thanks to its expertise in robotics and precision mechanics. Shark Robotics works in sectors like security, defence, industrial, and nuclear power. Goal of Shark Robotics is to keep the guy secure.

Series Unknown $10.8M
Forterra

Forterra offers self-driving systems for land-based transportation in various industries. The company is a pioneer in autonomous technology, creating systems that prioritize the safety of soldiers and enhance the productivity of civilian workers. Forterra is a leading supplier of autonomous solutions for the U.S. Department of Defense, using autonomy for strategic advantages in challenging environments.

Series C $238M
Chaos

CHAOS Industries is a technology company that is building the next generation of defense and critical industry technologies. Applying an engineering-led strategy, CHAOS provides mission-driven, world-class engineers with a platform to build solutions to critical real-world problems. The CHAOS agile engineering approach enables rapid prototyping, while deep partnerships with defense and industry ensure real-world application.

Series D $510M
SalesPatriot
Seed $5.0M
ZeroMark

ZeroMark is a company that specializes in defense products and is developing technology to enhance safety and accuracy while using both kinetic and non-lethal weapons.

Seed $240k
Reconnect

Reconnect improves outcomes and provides ongoing support during pretrial, reentry, and recovery. Reconnect is a Public Benefit Company (PBC). This means that they put their mission into every decision they make as a company. They aim to have a positive impact on those who face addiction and who struggle within the criminal justice system, where they will promote the reduction of incarceration, the reduction of recidivism, and the reduction of costs, especially where those costs are borne by defendants in the system. It was founded in 2009 and is headquartered in Cumberland Center, Maine.

Venture - Series Unknown $3.3M
First Due

First Due is a software platform that aims to modernize fire and EMS records management by combining different operational tasks into one system. This platform centralizes important operations to assist public safety agencies in efficiently organizing their processes. First Due provides public safety organizations with a wide range of high-quality tools such as pre-incident planning, mobile response, ePCR, NERIS and NEMSIS-compliant reporting, scheduling, fire prevention and inspections, asset and inventory management, and community engagement, all within one integrated platform.

Series Unknown $355M
Performance Drone Works

PDW is a family of small autonomous platforms designed for the modern warfighter. It has a record of developing novel technology across a large stack in suas design. Its systems share the common design in electronics and software across three different sized platforms.

Series Unknown
Rune Technologies

Rune Technologies creates TyrOS, an AI-enhanced predictive logistics system specifically made for military and challenging environments. The platform links, arranges, and evaluates important logistical data to offer instant and data-oriented decisions for logistical and maintenance systems. It provides smart planning, decision aid, and predictive analysis to improve accuracy, flexibility, and effectiveness in supply operations.

Series A $24.0M
Chariot Defense

Chariot Defense is creating advanced hardware and software systems to tackle the main issue faced by the military: effectively managing and utilizing energy to generate power in modern warfare.

Seed $8.0M
Impala

Impala creates a data-driven platform that makes it easier and quicker to explore nonprofits, fundraise, search for partners, and do good across a variety of nonprofit sectors. They help to analyze how the partners, funders, board members and stakeholders are connected.

Series Unknown $1.3M
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.